Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.24%6.4B | -0.38%1.59B | 4.15%1.58B | -0.06%1.61B | 5.46%1.62B | 1.44%6.26B | 7.61%1.6B | -1.17%1.52B | 1.45%1.61B | -1.85%1.54B |
Operating revenue | 2.24%6.4B | -0.38%1.59B | 4.15%1.58B | -0.06%1.61B | 5.46%1.62B | 1.44%6.26B | 7.61%1.6B | -1.17%1.52B | 1.45%1.61B | -1.85%1.54B |
Cost of revenue | 6.88%2.69B | 1.90%696M | 7.68%659M | 4.38%668M | 14.66%665M | 9.63%2.52B | 14.98%683M | 11.07%612M | 8.84%640M | 3.39%580M |
Gross profit | -0.88%3.72B | -2.08%896M | 1.76%923M | -3.00%939M | -0.10%957M | -3.40%3.75B | 2.69%915M | -8.01%907M | -2.91%968M | -4.77%958M |
Operating expense | -7.93%2.23B | -0.50%600M | -21.04%533M | -4.49%553M | -3.72%543M | 11.31%2.42B | -1.47%603M | 19.05%675M | 9.45%579M | 20.77%564M |
Selling and administrative expenses | -7.03%1.76B | 0.21%470M | -21.56%422M | -3.10%437M | -0.92%431M | 11.09%1.89B | -0.21%469M | 22.27%538M | 6.62%451M | 17.25%435M |
Research and development costs | -11.17%469M | -2.99%130M | -18.98%111M | -9.38%116M | -13.18%112M | 12.10%528M | -5.63%134M | 7.87%137M | 20.75%128M | 34.38%129M |
Operating profit | 11.98%1.49B | -5.13%296M | 68.10%390M | -0.77%386M | 5.08%414M | -22.17%1.33B | 11.83%312M | -44.63%232M | -16.88%389M | -26.90%394M |
Net non-operating interest income expense | 1.33%-520M | -2.33%-132M | 5.97%-126M | 0.76%-131M | 0.76%-131M | -24.88%-527M | -8.40%-129M | -24.07%-134M | -34.69%-132M | -36.08%-132M |
Non-operating interest expense | -1.33%520M | 2.33%132M | -5.97%126M | -0.76%131M | -0.76%131M | 24.88%527M | 8.40%129M | 24.07%134M | 34.69%132M | 36.08%132M |
Other net income (expense) | -25.20%-159M | 55.70%-35M | -216.67%-57M | -566.67%-20M | -74.07%-47M | 21.12%-127M | -61.22%-79M | 37.93%-18M | 96.39%-3M | -27M |
Gain on sale of security | 38.10%-26M | 11.76%-15M | 57.14%-6M | 150.00%1M | 33.33%-6M | -281.82%-42M | 46.88%-17M | -250.00%-14M | -109.52%-2M | -325.00%-9M |
Special income (charges) | -60.00%-112M | 86.21%-8M | ---51M | ---15M | -216.67%-38M | 48.15%-70M | -241.18%-58M | --0 | --0 | ---12M |
-Less:Restructuring and merger&acquisition | -50.00%31M | -86.21%8M | --0 | --0 | 475.00%23M | 121.43%62M | 241.18%58M | --0 | --0 | --4M |
-Less:Other special charges | 912.50%81M | ---- | --51M | --15M | 87.50%15M | -92.52%8M | --0 | ---- | ---- | --8M |
Other non- operating income (expenses) | -40.00%-21M | -200.00%-12M | ---- | -500.00%-6M | 50.00%-3M | 0.00%-15M | ---4M | 0.00%-4M | 85.71%-1M | -50.00%-6M |
Income before tax | 19.91%807M | 24.04%129M | 158.75%207M | -7.48%235M | 0.43%236M | -40.02%673M | -6.31%104M | -71.63%80M | -11.50%254M | -46.83%235M |
Income tax | 83.71%-57M | 104.52%20M | -790.91%-152M | 233.33%40M | -39.66%35M | -270.73%-350M | -14,833.33%-442M | -60.00%22M | -77.36%12M | -38.30%58M |
Net income | -15.54%864M | -80.04%109M | 518.97%359M | -19.42%195M | 13.56%201M | 11.56%1.02B | 405.56%546M | -74.45%58M | 3.42%242M | -49.14%177M |
Net income continuous Operations | -15.54%864M | -80.04%109M | 518.97%359M | -19.42%195M | 13.56%201M | 11.56%1.02B | 405.56%546M | -74.45%58M | 3.42%242M | -49.14%177M |
Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Minority interest income | ||||||||||
Net income attributable to the parent company | -15.54%864M | -80.04%109M | 518.97%359M | -19.42%195M | 13.56%201M | 11.56%1.02B | 405.56%546M | -74.45%58M | 3.42%242M | -49.14%177M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -15.54%864M | -80.04%109M | 518.97%359M | -19.42%195M | 13.56%201M | 11.56%1.02B | 405.56%546M | -74.45%58M | 3.42%242M | -49.14%177M |
Basic earnings per share | -16.21%3.36 | -80.37%0.42 | 504.35%1.39 | -20.00%0.76 | 11.43%0.78 | 11.08%4.01 | 409.52%2.14 | -74.16%0.23 | 3.26%0.95 | -48.91%0.7 |
Diluted earnings per share | -16.54%3.33 | -80.28%0.42 | 500.00%1.38 | -21.05%0.75 | 13.04%0.78 | 11.14%3.99 | 407.14%2.13 | -74.16%0.23 | 3.26%0.95 | -49.26%0.69 |
Dividend per share | 0.00%1.12 | 0.00%0.28 | 0.00%0.28 | 0.00%0.28 | 0.00%0.28 | 0.00%1.12 | 0.00%0.28 | 0.00%0.28 | 0.00%0.28 | 0.00%0.28 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |